(YorkPedia Editorial):- Toronto, Ontario Feb 15, 2021 (Issuewire.com) – Microdose Psychedelic Insights, Universal Ibogaine along with The Conscious Fund, and ACS Pharmacology & Translational Science present The Ibogaine Conference: A Molecular Masterclass, a two-day virtual conference.
The online conference is taking place this week, Friday 19th and 20th February 2021. Starting at 8:45 am EST.
More on YorkPedia:
The Conference will focus on discussions by the world’s leading names and industry experts in the research of the therapeutic use of Ibogaine. Major topics and speakers include:
08:55 am – Opening Notes
09:00 am – Keynote: The Evolution of Ibogaine Treatment – Patrick Kroupa
10:00 am – Keynote: Ibogaine Treatment in the time of Covid-19 – Jeremy Weate
11:00 am – Panel: Clinical research: latest findings from ongoing studies – Alberto Solà, Sergey Khudoley, Rafael dos Santos
12:10 pm – Panel: The path to medicalization in Canada and elsewhere – Zappy Zapolin, Ian Campbell, Dan Schneider, Bruno Rasmussen, Colleen Clandening
01:20 pm – Keynote: Ibogaine: Beyond Anecdotes and Unsanctioned Use Towards Medication Development – Deborah Mash
02:30 pm – Keynote: Rick Doblin
03:40 pm – Keynote: Ricard Faura, Andrea Langlois
04:10 pm – How to influence politicians on new treatments, laws, and policies to reduce the Opioid and Addiction Pandemic – Dan The Pharmacist Schneider
04:50 pm – Panel: Ibogaine: a missing tool to combat the opioid crisis?- Hirpal Hundial, Shea Prueger, Theo Fleury, Geoff Noller
06:00 pm – Panel: Ibogaine medicalization: the role of capital markets – Shayne Nyquvest, Henri Sant-Cassia, Lindsay Hoover, Anne Philippi
07:10 pm – Keynote: Opiate use disorder Ibogaine detox in 137 patient series preliminary results- Alberto Solà
Saturday 20th February
08:25 am – Opening Notes
08:30 am – PsyTech Panel
09:00 am – Panel: Ibogaine therapy in an indigenous context: from the Bwiti experience to First Nations North America Uwe Maas, Frank Albo, Ian Campbell
10:00 am – Keynote: Iboga(ine) and Nagoya Protocol – Sustainable and Fair Trade – Yann Guignon & Paul Armand Mombey Indaki
11:10 am – Keynote: The Ibogaine State of Consciousness – Martie Underwood
12:20 pm – Keynote: Ibogaine and classic hallucinogens in substance disorders: therapeutic effects and mechanisms of action – Rafael dos Santos
01:30 pm – Keynote: Microdosing of Iboga and Ibogaine – a prototype tool for consciousness-hacking and its neuropharmacological implications – Tobias Erny
02:40 pm – Panel: Ibogaine pre and aftercare: reframing the addiction recovery paradigm – Juliana Mulligan, Sue Nielsen, Anders Beatty, Svea Nielsen, Laura Shapiro, Dr. Megan McElheran, CEO and Clinical Psychologist, Wayfound Mental Health Group
03:50 pm – Keynote: Neuropharmacology Renaissance in a New World – COVID19 Neurodegeneration and Emerging Applications of Ibogaine – Nikita Alexandrov
05:00 pm – Keynote: A Holotropic Perspective ~ Exploring the networks, fissures & reciprocity within the global ibogaine community – Clare Wilkins
06:10 pm – Panel: Ibogaine in the world: provider experiences – Garyth Moxey, Asha Caravelli, Shea Prueger, Allison Wiseman, Kimberly Adams
07:20 pm – Keynote: The emerging consensus on how ibogaine works – Dana Beal
Attendees will also have the opportunity to participate in panel discussions about the medicalization, support advocacy in different contexts as well as discuss the use of ibogaine as a therapy for addiction, neurodegenerative disorders, as well as a catalyst for spiritual development.
When asked what can attendees expect to learn at the Ibogaine Conference? Prof. Rafael Guimarães dos Santos, Ph.D., Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo said: ”The most updated information regarding the mechanisms of action of ibogaine and other hallucinogens and their most relevant clinical potentials derived from clinical trials.”
On the importance of the events such as Ibogaine Masterclass, Dr. Bruno Rasmussen Chaves remarked: ”I think that events like this are important for the industry because people must be informed and educated about ibogaine, there are a lot of misconceptions involved and it is our obligation to clarify them all.”
“Attendees can expect to hear about Bwete as the science and tradition of Iboga, as well as offering alternatives to the misappropriation of this resource and its ancestral knowledge.” – Paul Armand MOMBEY-INDAKI, Bwete Master
Dan The Pharmacist Schneider added: ” With the Overdose deaths due to the Opioid and Addiction Pandemic at record levels, we need to see more and better treatments. I believe that Ibogaine will be one of the newer treatments that will increase success rates leading to recovery and saving lives.”
To learn more about the conference, subscribe to event updates and speakers lists visit https://microdose.buzz/shop/molecular-masterclass/ibogaine-conference/. Click here to register for a complimentary press pass and early access to the networking lounge. 100% discount is applied at the checkout.
– ENDS –
Notes to Editors
About Microdose Psychedelic Insights
Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy, and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and their intersection with healthcare, medicine, and personal growth. We work with the industry’s most influential stakeholders, some of the world’s best-known brands, and an unrivaled network of scientists, researchers, analysts, innovators, investors, and advisors.
About Universal Ibogaine
Universal Ibogaine is a Canadian company poised to address the opioid epidemic through proven plant medicine. We intend to operate and franchise clinics with a safe and effective, seven-day treatment using ibogaine to break the cycle of addiction. Our Mission is a solution to the opioid crisis and changing attitudes towards vibrant new medical solutions. https://www.ibogaineinc.com